No results for ‘’
TCM Ltd
₹45.06
(4.13%)
Wed, 16 Sept 2026, 08:08 am
Process Industries
Chemicals: Specialty
24.5KTCM Ratios
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51.46 | 114.99 | 0 | 0 | 0 | 16.58 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.73 | 0.50 | 0.48 | 0.42 | 0.65 | 0.81 | 1.43 | 0.88 |
| Price to sales ratio | 1.60 | 2.06 | 10.46 | 146.27 | 0 | 0 | 0 | 0 | 0 | 0 | 40.98 | 17.04 | 3.21 | 4.64 | 3.02 | 1.16 | 1.06 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.16 | 0 | 0 | 20.16 | 0 |
| Enterprise value | 21.69Cr | 36.3Cr | 37.84Cr | 45.78Cr | 48.04Cr | 47.37Cr | 47.91Cr | 52.15Cr | 40.3Cr | 30.02Cr | 17.89Cr | 17.34Cr | 19.37Cr | 21.63Cr | 22.67Cr | 35.54Cr | 36.23Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.16 | 0.17 | 0.17 | 0.18 | 0.26 | 0.05 | 0.01 | 0.37 |
| Return on equity % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -24.80 | -2.87 | 0.94 | 0.36 | -17.74 | -13.34 | -6.55 | 5.44 |
TCM Ltd Ratios
The TCM Ltd Ratios page provides a complete fundamental analysis of TCM Ltd using key valuation, profitability, and financial strength metrics. Investors tracking TCM Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
TCM Ltd (NSE: , BSE: 524156) is currently trading at ₹45.06, with a market capitalization of ₹33.72Cr. As a major player in the Process industries sector and Chemicals: specialty industry, TCM Ltd remains a key stock for fundamental analysis using TCM Ltd Ratios.
TCM Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The TCM Ltd P/E ratio currently stands at 16.58, making it one of the most tracked metrics in TCM Ltd Ratios.
Historically, the TCM Ltd P/E ratio has shown strong fluctuations:
- 2024: 16.58
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 114.99
The rising TCM Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The TCM Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.88.
Historical P/B trend:
- 2024: 0.88
- 2023: 1.43
- 2022: 0.81
- 2021: 0.65
TCM Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The TCM Ltd P/S ratio currently stands at 1.06, an important part of TCM Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 1.06
- 2023: 1.16
- 2022: 3.02
- 2021: 4.64
A stable or declining TCM Ltd P/S ratio indicates cautious market sentiment.
TCM Ltd Price to Cash Flow Ratio (P/CF)
The TCM Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.
Historical TCM Ltd Price to Cash Flow Ratio:
- 2024: 0
- 2023: 20.16
- 2022: 0
- 2021: 0
- 2020: 35.16
The declining TCM Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
TCM Ltd Enterprise Value Ratios
Enterprise Value (EV)
The TCM Ltd EV currently stands at ₹36.23Cr, representing the total company valuation including debt.
Historical EV trend:
- 2024: 36.23Cr
- 2023: 35.54Cr
- 2022: 22.67Cr
- 2021: 21.63Cr
TCM Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The TCM Ltd EV/EBITDA ratio is currently 0, a key metric in TCM Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
Stable TCM Ltd EV/EBITDA indicates balanced valuation.
TCM Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The TCM Ltd D/E ratio is currently 0.37, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.37
- 2023: 0.01
- 2022: 0.05
- 2021: 0.26
TCM Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The TCM Ltd ROE currently stands at 5.44%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 5.44
- 2023: -6.55
- 2022: -13.34
- 2021: -17.74
Declining ROE indicates pressure on profitability.
TCM Ltd Ratios Analysis Summary
The TCM Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether TCM Ltd stock is undervalued, fairly valued, or overvalued.
Tracking TCM Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.